Randomized controlled trial to evaluate the utility of suction and inner-stylet of EBUS-TBNA for mediastinal and hilar lymphadenopathy.

Xiaoxiao Lin, Min Ye, Yuping Li, Jing Ren, Qiyan Lou, Yangyang Li, Xiaohui Jin, Ko-Pen Wang, Chengshui Chen
Author Information
  1. Xiaoxiao Lin: Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, Ouhai District, Wenzhou, China.
  2. Min Ye: Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, Ouhai District, Wenzhou, China.
  3. Yuping Li: Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, Ouhai District, Wenzhou, China.
  4. Jing Ren: Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, Ouhai District, Wenzhou, China.
  5. Qiyan Lou: Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, Ouhai District, Wenzhou, China.
  6. Yangyang Li: Department of Pathology, The First Affiliated Hospital of Wenzhou Medical University, Ouhai District, Wenzhou, China.
  7. Xiaohui Jin: Department of Endoscopy, The First Affiliated Hospital of Wenzhou Medical University, Ouhai District, Wenzhou, China.
  8. Ko-Pen Wang: Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, USA.
  9. Chengshui Chen: Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, Ouhai District, Wenzhou, China. wzchencs@163.com. ORCID

Abstract

BACKGROUND: The optimal procedure for maximizing the diagnostic yield and minimizing the procedural complexity of endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is controversial. We conducted a prospective randomized controlled trial to determine the optimal procedure of EBUS-TBNA for mediastinal and hilar lymphadenopathy, with a particular focus on the roles of the inner-stylet and suction.
METHODS: Consecutive patients with enlarged mediastinal and hilar lymph nodes (LNs), detected by computed tomography (CT) or positron emission tomography-CT (PET-CT), who underwent EBUS-TBNA were included. Each LN was sampled with three needle passes using suction-stylet, suction-no stylet, and stylet-no suction procedures. The samples were smeared onto glass slides for cytological evaluation. A single, blinded cytopathologist evaluated each set of slides. The primary outcomes were cytological specimen adequacy rate and diagnostic yield of malignant LNs. The secondary outcomes were tissue-core acquisition rate, procedural time, and the amount of bleeding.
RESULTS: This study evaluated 97 patients with a total of 255 LNs. The final LN diagnosis was benign in 144, malignant in 104, and inadequate in 7 cases. There were no significant differences among the suction-stylet, suction-no stylet, and stylet-no suction groups in specimen adequacy rate (87.1, 88.2, 85.9%, respectively) or diagnostic yield of malignancy (32.2, 31.8, 31.0%, respectively). However, the use of suction was associated with an increase in tissue-core acquisition rate (P <  0.001). The no-stylet procedure decreased the average procedural time by 14 s (P <  0.001). There was no significant difference in the amount of bleeding among the procedures.
CONCLUSIONS: The use of suction or non-use of an inner-stylet does not make a significant difference in cytological specimen adequacy or diagnostic yield when performing EBUS-TBNA. While omitting the stylet can simplify the procedure, applying suction can increase the tissue-core acquisition rate. These findings may assist endoscopic physicians in determining the optimal EBUS-TBNA procedure and warrant clinical verification in a future multicentre study.
TRIAL REGISTRATION: Trial registration: ( ChiCTR-IOR-17010616 ). Retrospective registered date: 12th February, 2017.

Keywords

References

  1. Chest. 2013 May;143(5 Suppl):e211S-e250S [PMID: 23649440]
  2. Eur Respir J. 2015 Oct;46(4):1140-9 [PMID: 26160875]
  3. PLoS One. 2013 Dec 05;8(12):e82787 [PMID: 24340058]
  4. Am J Respir Crit Care Med. 2015 Apr 1;191(7):796-803 [PMID: 25574801]
  5. Respiration. 2014;87(4):343-51 [PMID: 24434575]
  6. J Thorac Oncol. 2008 Jun;3(6):577-82 [PMID: 18520794]
  7. Cancer Cytopathol. 2014 Apr;122(4):239-40 [PMID: 24500810]
  8. Thorax. 2011 Oct;66(10):889-93 [PMID: 21813622]
  9. Chest. 2016 Apr;149(4):1111-3 [PMID: 27055709]
  10. Respiration. 2014;88(6):500-17 [PMID: 25377908]
  11. Diagn Cytopathol. 2018 May;46(5):378-383 [PMID: 29476608]
  12. Am J Respir Crit Care Med. 2012 Jun 15;185(12):1316-22 [PMID: 22505743]
  13. Endoscopy. 2015 Jun;47(6):545-59 [PMID: 26030890]
  14. Chest. 2008 Aug;134(2):368-374 [PMID: 18263688]
  15. J Thorac Oncol. 2009 May;4(5):568-77 [PMID: 19357537]
  16. Chest. 2017 Mar;151(3):636-642 [PMID: 27769775]
  17. Endosc Ultrasound. 2016 Jan-Feb;5(1):43-8 [PMID: 26879166]
  18. Thorax. 2014 Jul;69(7):679-81 [PMID: 24064440]
  19. Chest. 2012 Sep;142(3):568-573 [PMID: 22156610]
  20. Chest. 2007 Sep;132(3 Suppl):202S-220S [PMID: 17873169]
  21. Am J Clin Pathol. 2008 Sep;130(3):434-43 [PMID: 18701418]
  22. Respir Res. 2013 May 10;14:50 [PMID: 23663438]
  23. J Thorac Oncol. 2013 Jul;8(7):823-59 [PMID: 23552377]
  24. J Thorac Dis. 2016 Sep;8(9):2544-2550 [PMID: 27747007]
  25. Cancer Lett. 2016 Feb 28;371(2):182-6 [PMID: 26656954]
  26. Ann Thorac Surg. 2016 Nov;102(5):1747-1755 [PMID: 27637288]
  27. Gastrointest Endosc. 2001 Oct;54(4):441-7 [PMID: 11577304]
  28. JAMA. 2010 Nov 24;304(20):2245-52 [PMID: 21098770]

Grants

  1. No Number/the International Pulmonary Key Laboratory of Zhejiang Province
  2. No Number/the Interventional Pulmonology Key Laboratory of Wenzhou City
  3. No Number/the Interventional Pulmonology Innovation Subject of Zhejiang Province
  4. 81270313/the National Nature Science Foundation of China
  5. 81770074/the National Nature Science Foundation of China
  6. 81570075/the National Nature Science Foundation of China
  7. LZ15H010001/the Natural Science Foundation of Zhejiang Province
  8. WKJ-ZJ-1526/the Science Technology Department Foundation of Zhejiang Province
  9. 2016YFC1304000/the National Key R&D Program of China

MeSH Term

Aged
Dimensional Measurement Accuracy
Endoscopic Ultrasound-Guided Fine Needle Aspiration
Female
Humans
Lymph Nodes
Lymphadenopathy
Male
Mediastinum
Middle Aged
Neoplasm Staging
Neoplasms
Positron Emission Tomography Computed Tomography
Specimen Handling
Tomography, X-Ray Computed
Treatment Outcome

Word Cloud

Created with Highcharts 10.0.0suctionEBUS-TBNAprocedureratediagnosticyieldoptimalproceduralneedletrialmediastinalhilarinner-styletLNsstyletcytologicalspecimenadequacytissue-coreacquisitionsignificantultrasound-guidedtransbronchialaspirationcontrolledlymphadenopathypatientsLNsuction-styletsuction-nostylet-noproceduresslidesevaluatedoutcomesmalignanttimeamountbleedingstudyamong2respectively31useincreaseP <  0001differencecanBACKGROUND:maximizingminimizingcomplexityendobronchialcontroversialconductedprospectiverandomizeddetermineparticularfocusrolesMETHODS:ConsecutiveenlargedlymphnodesdetectedcomputedtomographyCTpositronemissiontomography-CTPET-CTunderwentincludedsampledthreepassesusingsamplessmearedontoglassevaluationsingleblindedcytopathologistsetprimarysecondaryRESULTS:97total255finaldiagnosisbenign144104inadequate7casesdifferencesgroups87188859%malignancy3280%Howeverassociatedno-styletdecreasedaverage14 sCONCLUSIONS:non-usemakeperformingomittingsimplifyapplyingfindingsmayassistendoscopicphysiciansdeterminingwarrantclinicalverificationfuturemulticentreTRIALREGISTRATION:Trialregistration:ChiCTR-IOR-17010616Retrospectiveregistereddate:12thFebruary2017RandomizedevaluateutilityClinicalEndobronchialLymphadenopathyMalignant

Similar Articles

Cited By